Flowers Mary E D, Martin Paul J
Division of Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., DS-290, PO Box 19024, Seattle, WA 98109-1024, USA.
Leuk Lymphoma. 2003 Jul;44(7):1141-6. doi: 10.1080/1042819031000079096.
During the past 5 years, better understanding of immunomodulatory and anti-angiogenesis properties of thalidomide has increased interest in the use of this agent for a wider variety of clinical applications. This article reviews the clinical evaluation of thalidomide for treatment or prevention of chronic graft-versus-host-disease.
在过去5年中，对沙利度胺免疫调节和抗血管生成特性的更深入了解，激发了人们对将该药物用于更广泛临床应用的兴趣。本文综述了沙利度胺治疗或预防慢性移植物抗宿主病的临床评估。
